Next, we investigated whether hepatic PTP4A1 overexpression by AAV-aat-Ptp4a1 could reveal metabolic benefits, including improved glucose homeostasis and NAFLD in WT mice fed an HF diet. Here, PTP4A1 is linked to metabolic dysfunction-associated steatotic liver disease.